In conclusion, these studies indicate that ambient concentrations of ozone may induce airway inflammation, through release of proinflammatory mediators from airway epithelial cells. This effect may be inhibited both by the anti-inflammatory drug, nedocromil sodium, and the naturally occurring antioxidant glutathione.
Epidemiological studies have demonstrated that there is a clear association between episodes of air pollution and impaired lung function, cough and infections of the lower respiratory tract [1] [2] [3] . Increases in the ambient concentration of O 3 , in particular, have been shown to decrease lung function and increase bronchial hyperresponsiveness, both in asthmatic and nonasthmatic children [4] [5] [6] . Studies investigating the pathophysiological effects resulting from inhalation of O 3 have demonstrated that this gas leads to marked histological change, including infiltration with inflammatory cells in the airways. Studies in Rhesus monkeys have demonstrated that, in addition to tracheal and bronchial epithelial damage, exposure for 8 h to 960 parts per billion (ppb) O 3 also led to neutrophil and eosinophil influx after 12-24 h [7] . Similarly, studies in humans have demonstrated that exposure of healthy volunteers for 4-7 h to 80-200 ppb O 3 induced epithelial damage and permeability and an increase in the number of neutrophils and several inflammatory mediators, in proximal airway lavage (PAL) and bronchoalveolar lavage (BAL) fluids collected 18-24 h after exposure [8, 9] .
Although the precise mechanisms underlying O 3 -induced inflammation of the airways are not clear, there is increasing evidence that airway epithelial cells may play a vital role, since they can express and synthesize a large variety of proinflammatory mediators, including eicosanoids, cytokines and cell adhesion molecules, which influence the growth, differentiation, proliferation and activation of inflammatory cells [10, 11] . More recently, we have demonstrated that exposure of human bronchial epithelial cells to nitrogen dioxide leads to significant release of interleukin-8 (IL-8), tumour necrosis factor-α (TNF-α), granulocyte/macrophage colony-stimulating factor (GM-CSF) and leukotriene C 4 (LTC 4 ) from these cells, in vitro [12, 13] .
In view of the detrimental effects of air pollutants at the airway epithelium and the likely importance of the epithelial cells in modulating airway inflammation, we hypothesized that airway inflammation observed after inhalation of O 3 is a result of increased synthesis and release of inflammatory mediators from airway epithelial cells and that anti-inflammatory agents inhibit the release of these mediators. To test this hypothesis, we investigated: 1) the effect of exposure for 6 h to 0-500 ppb O 3 , on epithelial cell membrane integrity and the release of IL-8, GM-CSF, TNF-α and soluble intercellular adhesion molecule-1 (sICAM-1) from human bronchial epithelial cells in vitro; and 2) the effect of both nedocromil sodium (10 -7 -10 -4 M), a nonsteroidal antiasthma drug, and glutathione (100-600 µM), a naturally occurring antioxidant compound, on any O 3 -induced release of these inflammatory mediators. The mediators investigated were selected since they are known to play an important role in the initiation and maintenance of airway inflammation, which can lead to airway hyperresponsiveness.
Materials and methods
All chemicals and reagents were of tissue culture grade and, unless otherwise stated, were obtained from the Sigma Chemical Co. (Poole, UK).
Culture of bronchial epithelial cells
Bronchial tissue was obtained from five male and six female patients, who underwent lobectomy or pneumonectomy for lung cancer, at St Bartholomew's Hospital, London. All patients were smokers, not allergic to common allergens, and of mean (±SEM) age 59±7 yrs (range 27-69 yrs). Following resection, only tissue macroscopically free of tumour was further processed for culture.
Bronchial epithelial cells were cultured by an explant cell culture technique developed in our laboratory [14] . Briefly, the epithelium was dissected away from the underlying tissue and cut into smaller sections, approximately 1-2 mm 3 in size. All the sections were gently washed three times in sterile prewarmed Medium 199 containing 1% (v/v) antibiotic/antimycotic solution composed of penicillin, streptomycin and amphotericin B (Sigma, UK). Then 2-3 sections were explanted into untreated 60 mm diameter Falcon® "Primaria™" plastic culture dishes (Becton Dickinson Ltd, Oxford, UK). The explants were incubated for 2-3 weeks at 37°C in a 5% CO 2 in air atmosphere, in 2.5 mL aliquots of fresh sterile complete culture medium prepared by mixing 250 µg bovine pancreatic insulin, 250 µg human transferrin, 36 µg hydrocortisone, 3 mg L-glutamine, 1 mL of antibiotic/antimycotic solution and 2.5 mL Nu-serum IV (Flow Laboratories, Scotland, UK) in 100 mL Medium 199. Once the outgrowing epithelial cells had grown to confluence, the explants were removed from each culture dish and the epithelial cells allowed to grow over the areas previously occupied by the explants. Randomly chosen cultures were checked for purity as described previously [14] .
Exposure of epithelial cell cultures to ozone
Exposure of cells to O 3 was carried out in an airtight polycarbonate aeration chamber, with a capacity of 5.5 L. Medium 199 , to remove any radio-label not incorporated into the cells. The cultures were exposed to 0-500 ppb O 3 for 6 h, as described above. At the end of exposure, the medium was collected and the cells were gently washed with 1.0 mL fresh ice-cold medium. The culture medium and the wash were pooled and the adherent cells were scraped off into 3.0 mL Medium 199. Aliquots, 200 µL in volume, of all samples were mixed with 5.0 mL of Ready-Solv™ CP scintillation cocktail (Beckman-RIIC Ltd, High Wycombe, UK), and were assessed for 51 Cr radioactivity using a Beckman LS1800 scintillation counter (Beckman-RIIC Ltd, High Wycombe, UK). All radioactivity released into the medium was expressed as a percentage of total in the culture, according to the formula:
Total cpm in medium ×100 Total cpm in medium + total cpm in cell pellet where cpm=counts per minute.
Effect of 0-500 ppb O 3 on the release of IL-8, GM-CSF, TNF-α and sICAM-1 from human bronchial epithelial cells
Two to three week old confluent cultures were used for all experiments. Prior to exposure to O 3 , cell cultures were equilibrated by incubation for 24 h in Medium 199 containing 1% serum-free supplement medium (SF-1 medium) (Northumbria Biologicals Ltd, Cramlington, UK). Following this initial incubation, the cultures were gently washed three times with prewarmed and preaerated SF-1 medium and sets of at least six cultures each from different individuals were exposed for 6 h to either 0 (air), 10, 50, 100 or 500 ppb O 3 , as described above. At the end of exposure, the medium was collected from each culture and the cells were gently washed with l.0 mL fresh ice-cold Medium 199. The wash was pooled with the culture medium and stored at -70°C until analysis for the various mediators. The adherent cells were scraped off into l.0 mL Medium 199 and stored at -70°C until analysis for cellular protein, according to the method of LOWRY et al. [15] . Prior to analysis, the media samples were concentrated by freeze drying and, following reconstitution in 1.0 mL distilled H 2 O, were analysed for IL-8, GM-CSF, TNF-α, and sICAM-1, using commercially available enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Abingdon, UK). All results were expressed as pg mediator·µg -1 cellular protein.
Effect of 10 -7 -10 -4 M nedocromil sodium on the release of IL-8, GM-CSF, TNF-α and sICAM-1 from human bronchial epithelial cells
Sets of 2-3 week old confluent cultures equilibrated for 24 h in SF-1 medium, as described above, were incubated for 6 h in the presence of 10 -4 -10 -7 M nedocromil sodium. At the end of incubation, the culture medium and the cells were collected and treated as above.
Effect of nedocromil sodium on O 3 -induced release of IL-8, GM-CSF, TNF-α and sICAM-1 from human bronchial epithelial cells
The first set of experiments indicated that O 3 -induced mediator release was maximal at a concentration of 50 ppb O 3 , and that IL-8 was the mediator which was released from the bronchial epithelial cells in greatest quantities. Subsequently, studies were undertaken to investigate the effect of 10 -7 -10 -4 M nedocromil sodium on 50 ppb O 3 -induced release of IL-8. On the basis of these findings, further studies were undertaken to investigate the effect of the optimal concentration (10 -5 M) of nedocromil sodium on 0-500 ppb O 3 -induced release of all the different mediators.
Thus, in the first instance, sets of 2-3 week old confluent cultures, equilibrated in SF-1 medium, were exposed for 6 h to 50 ppb O 3 in the presence of 10 -4 -10 -7 M nedocromil sodium. At the end of incubation, the culture medium and the cells were collected and analysed for IL-8 and total cell protein, respectively, as described above.
In the second instance, sets of 2-3 week old confluent cultures, equilibrated in SF-1 medium, were exposed for 6 h to 0-500 ppb O 3 , in the presence of 10 -5 M nedocromil sodium and, at the end of incubation, the culture medium and the cells were collected and analysed for the presence of IL-8, GM-CSF, TNF-α, sICAM-1 and total cell protein, respectively, as described above.
Effect of 0-600 µM glutathione on 50 ppb O 3 -induced release of IL-8 by human bronchial epithelial cells
Two to three week old cultures of bronchial epithelial cells were equilibrated in SF-1 medium for 24 h and then exposed for 6 h to 50 ppb O 3 in the presence of 0-600 µM glutathione. At the end of incubation, the medium and the cells were collected and analysed for IL-8 and total cell protein, respectively, as described above.
Statistical analysis
Results are expressed as mean±SEM. All results were tested for normality using a normal probability plot and the Shapiro-Wilk test, and then further tested by one-way analysis of variance (ANOVA) to test for significance of any differences across the O 3 exposed and treatment groups, followed by further analysis with Scheffé's multiple regression test to assess differences between individual treatment groups. In the case of 51 Cr release studies, results were analysed by the unpaired ttest and the Bonferroni correction applied. Probability values of less than 0.05 were considered to be significant.
Results
Studies of the effects of exposure for 6 h to O 3 demonstrated that this agent did not lead to any gross damage or detachment of the epithelial cells, as evidenced by light microscopy. More detailed studies investigating the effect of O 3 exposure on bronchial epithelial cell membrane integrity, however, demonstrated that this agent led to a dose-dependent release of 51 Cr, from cells "loaded" with 51 Cr overnight. Exposure of cells for 6 h to 10, 50, 100 and 500 ppb O 3 led to the release of 24± 2, 28±1, 35±6 and 39±8% 51 Cr, respectively (p<0.001 for all comparisons with 5.2±0.3% 51 Cr in control cultures) ( fig. 1) .
Exposure of human bronchial epithelial cells for 6 h to O 3 significantly increased the release of IL-8, GM-CSF, TNF-α and sICAM from these cells, at concentrations of 10-100 ppb O 3 . Figure 2 shows the effect of O 3 exposure on the release of IL-8. These studies demonstrated that O 3 had a dose-dependent effect on the release of this cytokine, and was optimally active at a concentration of 50 ppb, significantly increasing the release to 20.16±2.56 pg·µg -1 cellular protein (p<0.01), compared with 5.64± 0.58 pg·µg -1 cellular protein released from control cells exposed for 6 hours to air. Although significant release Analysis of the culture medium for the presence of sICAM-1 demonstrated that the release of this cell adhesion molecule was increased by exposure of human bronchial epithelial cells to 10-100 ppb O 3 and was maximal (increased eightfold) after exposure to 50 ppb O 3 (37.7±10.8 pg·µg -1 cellular protein; p<0.05), when compared to exposure to air for 6 h (4.53±0.45 pg·µg -1 cellular protein). 10 -5 M nedocromil sodium was also shown to be effective in attenuating O 3 -induced release of sICAM-1 from these cells ( fig. 6 ). : without nedocromil sodium;
: with nedocromil sodium. ppb: parts per billion. *: p<0.05 versus 0 ppb ozone; # : p<0.05, and ## : p<0.01 versus 0 M nedocromil sodium). 
Discussion
These studies have demonstrated that exposure of human bronchial epithelial cells for 6 h to 10-500 ppb O 3 leads to significant epithelial cell damage at all concentrations studied, and to significant release of IL-8, GM-CSF, TNF-α, and sICAM-1 at concentrations of 10-100 ppb O 3 , in vitro. Additionally, these studies have demonstrated that mediator release from the cells can be significantly attenuated by treatment of the cells with 10 -5 M nedocromil sodium and 400-600 µM glutathione. To our knowledge, this is the first report of the release of sICAM-1 by human bronchial epithelial cells and the inductive effect of O 3 on its release from these cells in vitro.
We have previously demonstrated that human bronchial epithelial cells cultured to confluence in vitro retain morphological and biochemical characteristics similar to those found in vivo [10, 14] , and therefore render this model useful in the study of epithelial cell physiology. More recently, we have characterized the different epithelial phenotypes that constitute the cultures and have demonstrated that, of the total, approximately 0.5% are goblet cells, 40-45% are ciliated epithelial cells, 35-40% are glandular epithelial cells and 20% are basal epithelial cells [16] .
Despite kinetic limitations and the lack of naturally occurring defence mechanisms, such as the presence of a "protective" epithelial lining fluid and endogenous "reducing" agents, which may limit the oxidant-induced cell damaging effect of O 3 , cultured human airway epithelial cells offer a suitable in vitro model to study the effects of direct exposure to this agent and the mechanism(s) underlying these effects in epithelial cells.
Although a well-balanced human epithelial lining fluid would undoubtedly present the most optimal culture medium for use in such studies, such standardized preparations are not yet available commercially. Although a further limitation of the present study is that epithelial cells were cultured from surgical tissues of lung cancer patients with a history of smoking, and would possibly react differently to oxidant stress when compared to epithelial cells from healthy nonsmokers, the findings of these studies are nonetheless valuable since they give an indication of the mechanisms underlying O 3 -induced airway inflammation and how antiinflammatory agents, such as nedocromil sodium, may influence this inflammation.
The finding from the present studies that O 3 can lead to dose-dependent effects in human bronchial epithelial cells, however, is in agreement with the findings of others who have employed different epithelial cell models. Our studies have demonstrated that exposure to O 3 produces a bell-shaped response curve for the release of cytokines, and suggest that whilst O 3 may have stimulatory effects on cytokine release at lower concentrations, such effects become inhibitory at the higher concentrations. The demonstration that exposure to O 3 exhibited a linear dose-response curve for epithelial cell damage, as indicated by increased release of radiolabelled chromium from prelabelled cells, suggests that the inhibitory effect on cytokine release from these cells observed at the highest concentration of 500 ppb O 3 may be due to direct toxicity of this agent leading to: 1) detrimental effects at the cell membrane level; and 2) inhibition of the mechanisms upregulating the expression and release of the cytokines.
Similarly, DEVLIN et al. [17] have studied the effect of exposure to O 3 for 1 h, on BEAS 2B immortalized human airway epithelial cell line, and demonstrated that this led to a significant increase in the amount of interleukin-6 (IL-6), IL-8 and fibronectin (Fn) released by these cells. Furthermore, these authors demonstrated that all concentrations of O 3 (100-1,000 ppb) were significantly cytotoxic to these cells. DUMLER et al. [18] , investigated the effects of exposure to O 3 using a primate epithelial cell model, and demonstrated that O 3 also produced dose-dependent cytotoxic effects in this model.
The present finding that O 3 is effective in inducing an inflammatory response, even at ambient concentrations of 50-100 ppb in vitro, also complements the findings of studies which have investigated the effect of exposure of human volunteers to O 3 at similar concentrations. DEVLIN and co-workers [8] have demonstrated that exposure of moderately exercising, healthy, nonsmoking individuals for 6.6 h to 80-100 ppb O 3 significantly increased the numbers of neutrophils, protein, IL-6, prostaglandin E 2 (PGE 2 ), fibronectin (Fn), and lactate dehydrogenase (LDH) in BAL fluid obtained from these individuals 18 h after exposure. Similarly, ARIS et al. [9] demonstrated that exposure of exercising, healthy subjects for 4 h to 200 ppb O 3 led to significant increases in neutrophils, protein, IL-8, GM-CSF, Fn, LDH and α 1 -antitrypsin, in PAL and BAL fluids obtained 18 h after exposure. These authors observed that the number of neutrophils increased significantly in bronchial biopsy tissue obtained 18 h after exposure to O 3 .
More recently, GWIZDALA et al. [19] demonstrated that, although there were no significant differences in spirometric values and symptom scores between asthmatics and healthy volunteers, after exposure for 6 h to 200 ppb O 3 , there were significant increases in IL-6, IL-8 and polymorphonuclear neutrophil (PMN) numbers in BAL fluid obtained 24 h postexposure in asthmatics only. These studies suggest that O 3 may preferentially increase the production of inflammatory cytokines and inflammatory cell influx in asthmatics, possibly leading to an acute exacerbation at a later stage. Indeed, recent studies by MOLFINO et al. [20] have demonstrated that exposure of asthmatics to O 3 120 ppb for 1 h increased the airway response of these individuals to inhaled allergen, as indicated by a significant decrease (by approximately 50%) in the dose of allergen required to produce a 15% fall in forced expiratory volume in one second (FEV1), when compared with exposure for 1 h to air.
Our finding that nedocromil sodium attenuates the release of inflammatory mediators from human bronchial epithelial cells in vitro, is in accordance with the findings of others. MATTOLI and co-workers [21, 22] demonstrated that 10 -5 M nedocromil sodium significantly decreased the release of GM-CSF and IL-8 from cultured human bronchial epithelial cells incubated with interleukin-1 (IL-1), but not from cells incubated in the absence of IL-1; in other words, constitutive release of this cytokine was not inhibited, as demonstrated in the present study.
Although several investigators have demonstrated that nedocromil sodium can inhibit the activation of different inflammatory cell types, including mast cells, eosinophils, monocytes, macrophages and platelets in vitro [23] [24] [25] [26] [27] , the precise mode of action of this drug has only recently become clear. Studies have demonstrated that both sodium cromoglycate [28] and nedocromil sodium [29] block a chloride ion channel in rat basophil leukaemia cells, and have suggested that inhibition of this or a similar channel may inhibit mast cell activation, since influx of chloride ions into the mast cell is in part a prerequisite for calcium influx [30] and subsequent activation of this cell type. Furthermore, regulation of chloride channels, which are involved in cell volume change and thus inflammation [31] , is also affected by nedocromil sodium [29, 32] .
The findings of the present study suggest that nedocromil sodium may mediate its anti-inflammatory effects, at least in part, by affecting the synthesis and/or release of inflammatory cytokines, which directly or indirectly influence differentiation, growth and migration of inflammatory cells. It is possible that the inhibitory action of nedocromil sodium on the chloride ion channel may result in the abrogation of the initial stages of the signal transduction cascade essential for cytokine gene activation. Irrespective of what the specific mechanism is likely to be for the activity of nedocromil sodium, there is at present no information on the levels of nedocromil sodium in vivo. This lack of information has been due, in part, to technical difficulties in measurements resulting from the drug being applied topically into the upper and lower airways. Also, since the recommended daily dosage of nedocromil sodium for prophylaxis of asthma is 8-16 mg, the in vivo levels of this drug at the site of application are likely to be much higher than the concentration of 10 -5 M nedocromil sodium investigated as the optimal concentration in these in vitro studies.
Our finding that glutathione is capable of reducing the O 3 -induced release of IL-8 in vitro at concentrations of 400 and 600 µM, which are comparable to those found in the epithelial lining fluid in vivo [33] , is both novel and important, since it suggests that the airway epithelial lining fluid is an important naturally occurring defence barrier, which acts to neutralize the oxidant stress from exposure to air pollutants, such as O 3 and NO 2 , in vivo. Although it is possible that the susceptibility of the epithelial cells to O 3 in vitro may additionally be a consequence of natural degradation of glutathione under culture conditions, several studies have demonstrated that this is unlikely to be the case. CHEEK et al. [34] studied the stability of cellular anti-oxidant defence systems in rat alveolar type II cells cultured over a period of 4 days, and demonstrated that during culture the antioxidant enzyme activities and glutathione content of the cells were maintained at levels similar to those found in freshly isolated cells prior to culture. Similarly, SIMON et al. [35] have demonstrated that the glutathione-dependent antioxidant system is not altered in their rat alveolar epithelial cell culture system over a period of 7 days.
In summary, the results of these studies suggest that ambient concentrations of O 3 , not normally found to be detrimental to health, may induce airway inflammation, through release of proinflammatory mediators from airway epithelial cells, an effect inhibited both by the anti-inflammatory drug, nedocromil sodium, and naturally occurring antioxidants, such as glutathione.
